SCHEMBL23917419

SCHEMBL23917419

Cn1nc(-c2ccc(Cl)nc2)c2c(N)ncnc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 14/20 0.60
PIK3CA P42336 14/20 0.60
PIK3CB P42338 14/20 0.60
PRKDC P78527 14/20 0.60
PIK3CG P48736 13/20 0.60
ABL1 P00519 13/20 0.60
SRC P12931 13/20 0.60
EGFR P00533 12/20 0.60
HCK P08631 12/20 0.60
MTOR P42345 11/20 0.60
EPHB4 P54760 11/20 0.60
KDR P35968 11/20 0.60
PI4KB Q9UBF8 3/20 0.58
NUDT14 O95848 1/20 0.58
NUDT5 Q9UKK9 1/20 0.58
CYP1A2 P05177 2/20 0.51
DAPK3 O43293 1/20 0.51
RIPK2 O43353 1/20 0.51
LCK P06239 1/20 0.51
FYN P06241 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13019672 0.85 SRC (0.69) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL128512 0.84 PIK3CD (0.60) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL18874071 0.84 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL18874072 0.82 PIK3CD (0.62) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL130502 0.81 PIK3CD (0.60) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL12366 0.81 NUDT14 (0.69) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL30782445 0.81 NUDT14 (0.69) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL13826003 0.80 SRC (0.68) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL130503 0.80 PIK3CD (0.60) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL21436859 0.80 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB PIK3CD 2/4885PIK3CA 6/4885PIK3CB 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.